Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Gene Delivery Technologies Market?

Over the past few years, the gene delivery technologies market has seen quick expansion. It is set to grow from $3.79 billion in 2024 to $4.29 billion in 2025, with a compound annual growth rate (CAGR) of 13.3%. This substantial growth in the historical period is a result of improved knowledge of genetic diseases, progression in cell therapy, nanotechnology development, an increase in gene therapy trials, and a surge in research funding.

The market size of gene delivery technologies is anticipated to experience swift expansion in the coming years, reaching a size of $7.4 billion by 2029, with a compounded annual growth rate (CAGR) of 14.6%. The forecasted growth can be credited to advancements in precision medicine, improvements in regulatory frameworks, increased prevalence of gene therapy, and the growth of non-viral delivery systems. Notable trends for the forecast period encompass applications in rare diseases, an increase in clinical trials, targeted drug delivery, expansion of cell therapy, and the evolution of gene editing tools.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp

What Market Forces Are Contributing To The Growth Of The Gene Delivery Technologies Market?

Anticipated growth in the gene delivery technologies market is linked to the rise in the number of cell and gene therapies. These therapies, known for altering genetic and cellular composition to treat and alleviate diseases, owe their increment to advancements in gene editing technologies, which are crucial in the development and commercialization of these treatments. For instance, Association of the British Pharmaceutical Industry, a UK-based trade sector, informed that in August 2024, the historical rate of two ATMPs approvals per year by the UK medical regulation body is projected to increase to 10-15 approvals per year by 2030. This implies that the number of patients benefiting from these therapies in the UK could witness a rise from 2,500 in 2021 to potentially 10,000 annually by 2028. Consequently, the surge in cell and gene therapies propels the growth of the gene delivery technologies market.

Which Segmentation Factors Are Critical In The Gene Delivery Technologies Market Analysis?

The gene delivery technologiesmarket covered in this report is segmented –

1) By Mode: Biological; Chemical; Physical

2) By Method: Ex Vivo; In Vivo; In Vitro

3) By Application: Gene Therapy; Cell Therapy; Vaccines; Research

Subsegments:

1) By Biological: Viral Vectors; Bacterial Vectors; Lipid Nanoparticles

2) By Chemical: Cationic Lipids; Polymers; Chemical Transfection Agents

3) By Physical: Electroporation; Microinjection; Gene Gun; Sonoporation

How Are Global Trends Impacting The Development Of The Gene Delivery Technologies Market?

The rise of technological innovation has become a predominant trend gaining traction in the gene delivery technologies market. Leading contenders in the market are focusing their resources on developing technologically superior products to consolidate their market position. For example, in February 2023, a biotechnology firm based in the US, Aera Therapeutics, introduced Aera’s Platform delivery technology with an aim to uncover the potential of genetic medicines. The PNP technology of Aera permits accurate targeting of RNA molecules implicated in disease pathways. This technology paves the way for specific editing of genes within a patient’s cells, presenting opportunities for custom-tailored gene therapies.

Which Organizations Are At The Forefront Of The Gene Delivery Technologies Market?

Major companies operating in the gene delivery technologies market include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Which Region Is Leading Innovation In The Gene Delivery Technologies Market?

North America was the largest region in the gene delivery technologies market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10706&type=smp

Browse Through More Reports Similar to the Global Gene Delivery Technologies Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Nutritional Feed Additives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Pharmacies And Drug Stores Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model